検索結果

发表论文 | 研究与开发 | 千寿制药株式会社

愛媛大学医学部眼科学教室　2)千寿製薬株式会社　3)日野病院 あたらしい眼科42(12)：1566～1576 Efficacy and Safety of SJP-0132 in Patients <b>withb> Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuk...

「If I were you」に基づく研究開発 点眼剤の製剤開発と創意工夫 | SENJU SENSE | 千寿製薬について | 千寿製薬株式会社

眼しやすくするといった「製剤開発でできること」によって、患者さんのQOL**向上に少しでも貢献することが私たちの使命です。 * Kashiwagi K., Furuya T. Persistence <b>withb> topical glaucoma therapy among newly diagnosed Japanese patients. Japanese Journal of Ophthalmo...

Animal Science | Business Activities | About Senju | SENJU Pharmaceutical

Evolving into a Senses-Enhancing Enterprise <b>withb> a Consummate Pet-related Product Line Pets are our precious companions. They have the right to enjoy the same comforts we do. Through the development o...

学会发表 | 研究与开发 | 千寿制药株式会社

開催地：Salt Lake City, Utah, United States of America Establishment of in vitro drug evaluation model <b>withb> retinal ganglion cells from Leber’s hereditary optic neuropathy (LHON) patient-derived iPSC R.I...

FDA alerts health care professionals, compounders and patients of potential safety risks associated <b>withb> sulfite- containing compounded drugs （https://www.fda.gov/drugs/human-drug-compounding/fda-aler...